Liarozole dihydrochloride
Catalog No. A21853
Liarozole dihydrochloride (R75251; R85246) is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
Catalog Num | A21853 |
---|---|
M. Wt | 381.69 |
Formula | C17H15Cl3N4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1883548-96-6 |
Synonyms | R75251 dihydrochloride, R 75251, R-75251 |
SMILES | ClC1=CC(C(C2=CC=C3N=CNC3=C2)N4C=CN=C4)=CC=C1.[H]Cl.[H]Cl |
Liarozole dihydrochloride (R75251; R85246) is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.2 mL | 131 mL | 261.99 mL |
0.5 mM | 5.24 mL | 26.2 mL | 52.4 mL |
1 mM | 2.62 mL | 13.1 mL | 26.2 mL |
5 mM | 0.52 mL | 2.62 mL | 5.24 mL |
*The above data is based on the productmolecular weight 381.69. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.